D.E. Shaw & Co
FLGT icon

D.E. Shaw & Co’s Fulgent Genetics FLGT Stock Holding History

D.E. Shaw & Co’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.74M Sell
486,770
-214,535
-31% -$4.66M ﹤0.01% 1832
2025
Q4 		$18.4M Buy
701,305
+133,535
+24% +$3.46M 0.01% 1300
2025
Q3 		$12.8M Buy
567,770
+91,282
+19% +$1.88M 0.01% 1491
2025
Q2 		$9.47M Buy
476,488
+36,472
+8% +$711K 0.01% 1534
2025
Q1 		$7.44M Buy
440,016
+309,332
+237% +$5.27M 0.01% 1613
2024
Q4 		$2.41M Buy
130,684
+73,843
+130% +$1.44M ﹤0.01% 2582
2024
Q3 		$1.24M Sell
56,841
-75,503
-57% -$1.69M ﹤0.01% 3111
2024
Q2 		$2.6M Sell
132,344
-2,584
-2% -$53.9K ﹤0.01% 2410
2024
Q1 		$2.93M Buy
134,928
+94,233
+232% +$2.34M ﹤0.01% 2332
2023
Q4 		$1.18M Sell
40,695
-2,548
-6% -$68.2K ﹤0.01% 3032
2023
Q3 		$1.16M Sell
43,243
-1,350
-3% -$46.1K ﹤0.01% 2977
2023
Q2 		$1.65M Sell
44,593
-34,399
-44% -$1.2M ﹤0.01% 2756
2023
Q1 		$2.47M Buy
78,992
+42,496
+116% +$1.37M ﹤0.01% 2531
2022
Q4 		$1.09M Buy
36,496
+10,026
+38% +$359K ﹤0.01% 3382
2022
Q3 		$1.01M Buy
26,470
+5,870
+28% +$294K ﹤0.01% 3587
2022
Q2 		$1.12M Buy
20,600
+8,900
+76% +$489K ﹤0.01% 3558
2022
Q1 		$730K Buy
+11,700
New +$770K ﹤0.01% 4140
2021
Q2 		– Sell
-5,905
Closed -$571K – 4827
2021
Q1 		$571K Buy
+5,905
New +$610K ﹤0.01% 3447

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

D.E. Shaw & Co's FLGT Position: Q1 2026 in Review

D.E. Shaw & Co reduced its Fulgent Genetics (FLGT) stake by 31% in Q1 2026, selling an estimated $4.66M and leaving 486,770 shares worth $7.74M. The position accounts for ﹤0.01% of the portfolio, ranked #1832.

D.E. Shaw & Co first reported a position in FLGT in Q1 2021 and has held it in 18 quarters since. The position peaked at $18.4M in Q4 2025. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • D.E. Shaw & Co held 486,770 shares of Fulgent Genetics worth $7.74M as of Q1 2026.
  • D.E. Shaw & Co sold 214,535 Fulgent Genetics shares in Q1 2026, an estimated $4.66M.
  • Fulgent Genetics made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #1832 holding.
  • D.E. Shaw & Co first reported a position in Fulgent Genetics in Q1 2021 and has held it in 18 quarters since.
  • D.E. Shaw & Co's Fulgent Genetics position peaked at $18.4M in Q4 2025.
  • 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.